📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols. (2025)

First Author: Ursino M

Attributed to: MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2024.102988

PubMed Identifier: 39877554

Publication URI: http://europepmc.org/abstract/MED/39877554

Type: Journal Article/Review

Volume: 79

Parent Publication: EClinicalMedicine

ISSN: 2589-5370